Leptin, a circulating hormone secreted mainly from adipose tissues, is involved in the control of body weight. The plasma concentrations are correlated with body mass index, and are reported to be high in patients with insulin resistance, which is one of the major risk factors for cardiovascular disease. However, the direct effect of leptin on vascular wall cells is not fully understood. In this study, we investigated the effects of leptin on reactive oxygen species (ROS) generation and expression of monocyte chemoattractant protein-1 (MCP-1) in bovine aortic endothelial cells (BAEC). We found that leptin increases ROS generation in BAEC in a dose-dependent manner and that its effects are additive with those of glucose. Rotenone, thenoyltrifluoroacetone (TTFA), carbonyl cyanide m-chlorophenylhydrazone (CCCP), Mn(III)tetrakis (4-benzoic acid) porphyrin (MnTBAP), uncoupling protein-1 (UCP1) HVJ-liposomes, or manganese superoxide dismutase (MnSOD) HVJ-liposomes completely prevented the effect of leptin, suggesting that ROS arise from mitochondrial electron transport. Leptin increased fatty acid oxidation by stimulating the activity of carnitine palmitoyltransferase-1 (CPT-1) and inhibiting that of acetyl-CoA carboxylase (ACC), pace-setting enzymes for fatty acid oxidation and synthesis, respectively. Leptininduced ROS generation, CPT-1 activation, ACC inhibition, and MCP-1 overproduction were found to be completely prevented by either genistein, a tyrosine kinase inhibitor, H-89, a protein kinase A (PKA) inhibitor, or tetradecylglycidate, a CPT-1 inhibitor. Leptin activated PKA, and the effects of leptin were inhibited by the cAMP antagonist Rp-cAMPS. These results suggest that leptin induces ROS generation by increasing fatty acid oxidation via PKA activation, which may play an important role in the progression of atherosclerosis in insulinresistant obese diabetic patients.Leptin, a circulating hormone secreted mainly by adipose tissues, is involved in the control of body weight through the effects on food intake and energy expenditure (1, 2). In humans, the plasma concentrations of leptin are markedly correlated with body mass index and are also reported to be higher in insulin-resistant first-degree relatives of patients with non-insulin-dependent diabetes mellitus (NIDDM) 1 and type I diabetes compared with normal individuals (3-5). Disorders associated with hyperleptinemia such as obesity and insulin resistance are major risk factors for cardiovascular diseases (6, 7). Recently, the leptin receptor has been identified on endothelial cells, and leptin has been shown to promote both angiogenesis and inflammation (8, 9). However, the mechanism by which leptin induces inflammation remains to be elucidated.Adipocytes have recently been shown to secrete pro-inflammatory cytokines such as tumor necrosis factor-␣ and interleukin-6 (10, 11), and plasminogen activator inhibitor-1, a serine protease inhibitor of fibrinolysis, which together may play an active role in the pathogenesis of accelerated atherosclerosis in dia...